-+ 0.00%
-+ 0.00%
-+ 0.00%

Shaanxi Micot Receives RMB 960,000 in Government Funding for MT200605 Research

PUBT·11/04/2026 14:59:19
Listen to the news
Shaanxi Micot Receives RMB 960,000 in Government Funding for MT200605 Research
  • Shaanxi Micot received RMB 960,000 in initial central government funding for MT200605 clinical development.
  • The national innovative drug development project is jointly undertaken with Beijing Tiantan Hospital, Capital Medical University.
  • The hospital’s ethics committee also cleared MT200605’s Phase III trial for acute ischemic stroke.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shaanxi Micot Pharmaceutical Technology Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20261104-12400884), on November 04, 2026, and is solely responsible for the information contained therein.